Victory Capital Management Inc Fulcrum Therapeutics, Inc. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$4.2 - $24.0 $4,641 - $26,520	1,105 Added 3.82%	30,012 $147,000
Q1 2022 May 04, 2022	BUY	$9.96 - $23.65 $287,913 - $683,650	28,907 New	28,907 $278,000
Q2 2020 Aug 07, 2020	SELL	$9.11 - $22.06 $38,617 - $93,512	-4,239 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$9.49 - $21.26 $2,676 - $5,995	282 Added 7.13%	4,239 $51,000
Q4 2019 Feb 06, 2020	BUY	$4.46 - $18.14 $503 - $2,049	113 Added 2.94%	3,957 $66,000
Q4 2019 Feb 04, 2020	SELL	$4.46 - $18.14 $35,376 - $143,886	-7,932 Reduced 67.36%	3,844 $66,000
Q3 2019 Nov 12, 2019	BUY	$6.64 - $14.89 $78,192 - $175,344	11,776 New	11,776 $78,000

149

51.9M

6.91M

1.89M

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $198M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.